Contract Pharmaceuticals Limited Canada 2024-03-13 Health moderate FDA
Health · FDA · Recall #FDA-D-0364-2024
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and… Recall
Issued March 13, 2024 · Contract Pharmaceuticals Limited Canada
In March 2024, Contract Pharmaceuticals Limited Canada recalled the Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
What you should do
- 1 Stop using Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Contract Pharmaceuticals Limited Canada to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Contract Pharmaceuticals Limited Canada
- Category
- Health
- Recall date
- March 13, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the U.S. and Puerto Rico
- Recall number
- FDA-D-0364-2024
- Made in
- Canada
- Issuing agency
- FDA
In context
- Contract Pharmaceuticals Limited Canada has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.